Table 8.
Prevalence of adverse event experience.
| Sexual Enhancement (926 Males) | Weight Loss (987 Females) | p-Value | |||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Experienced adverse events; Yes | 163 | 17.6 | 121 | 12.3 | 0.001 |
| Symptoms 1 | |||||
| Nausea or heartburn | 31 | 19.0 | 31 | 25.6 | 0.183 |
| Gastrointestinal symptoms 2 | 44 | 27.0 | 65 | 53.7 | <0.001 |
| Headaches | 35 | 21.5 | 12 | 9.9 | 0.010 |
| Cutaneous symptom | 23 | 14.1 | 14 | 11.6 | 0.529 |
| Warmth or redness in the face, neck, or chest | 59 | 36.2 | 4 | 3.3 | <0.001 |
| Dizziness | 15 | 9.2 | 5 | 4.1 | 0.099 |
| Fatigue | 16 | 9.8 | 9 | 7.4 | 0.484 |
| Palpitation or shortness of breath | 16 | 9.8 | 5 | 4.1 | 0.070 |
| Others | 7 | 4.3 | 5 | 4.1 | 0.946 |
Note: The differences among gender groups were examined by Chi-square test (p < 0.05). 1 multiple answers. 2 Diarrhea, constipation, or stomach pains.